Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.45 EUR | +0.52% | +8.24% | -32.07% |
11:33am | EVOTEC : Receives a Buy rating from Jefferies | ZD |
Mar. 14 | Tubulis Technologies announced that it has received ?128 million in funding from a group of investors | CI |
Business Summary
Number of employees: 5,086
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
EVT Execute
72.8
%
| 471 | 76.2 % | 547 | 72.8 % | +16.06% |
EVT Innovate
27.2
%
| 147 | 23.8 % | 205 | 27.2 % | +39.29% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
55.7
%
| 338 | 54.6 % | 418 | 55.7 % | +23.90% |
Rest of the World
16.9
%
| 98 | 15.9 % | 127 | 16.9 % | +28.85% |
United Kingdom
15.3
%
| 105 | 16.9 % | 115 | 15.3 % | +10.15% |
Germany
7.8
%
| 47 | 7.6 % | 59 | 7.8 % | +25.70% |
France
4.3
%
| 31 | 4.9 % | 32 | 4.3 % | +5.50% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19-06-18 |
Laetitia Rouxel
DFI | Director of Finance/CFO | 51 | 23-02-06 |
Craig Johnstone
COO | Chief Operating Officer | 54 | 12-04-30 |
Cord Dohrmann
CTO | Chief Tech/Sci/R&D Officer | 60 | 10-08-31 |
Gabriele Hansen
IRO | Public Communications Contact | - | - |
Volker Braun
IRC | Investor Relations Contact | - | - |
Matthias Evers
PRN | Corporate Officer/Principal | 51 | 22-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19-06-18 |
Roland Sackers
BRD | Director/Board Member | 56 | 19-06-18 |
Chairman | 63 | 14-06-16 | |
Elaine Sullivan
BRD | Director/Board Member | 63 | 15-06-08 |
Director/Board Member | 41 | 22-06-21 | |
Director/Board Member | 62 | 21-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 177,542,097 | 160,933,134 ( 90.65 %) | 249,915 ( 0.1408 %) | 90.65 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
EXSCIENTIA PLC 11.86% | 14,035,200 | 11.86% | 93,334,080 $ |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Evotec International GmbH
Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Evotec International GmbH develops and provides drugs for the treatment of CNS disorders. It focuses on Alzheimer's disease and other neurological disorders. The company was founded in 1999 and is headquartered in Hamburg, Germany. |
Miscellaneous Commercial Services
|
Aptuit (Verona) Srl
Aptuit (Verona) Srl Pharmaceuticals: MajorHealth Technology Aptuit (Verona) Srl engages in the provision of integrated drug development solutions. It offers Indigo and Indigo-Select. The company was founded in 2004 and is headquartered in Verona, Italy. |
Pharmaceuticals: Major
|
Evotec (France) SAS
Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (France) SAS is a French company that engages in research and development of physical and natural sciences. The private company is based in Toulouse, France. The company was founded in 2014. Pierre Cooremans has been the CEO of the company since 2019. |
Miscellaneous Commercial Services
|
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The private company is based in Abingdon, UK and was founded in 1991. |
Miscellaneous Commercial Services
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.64% | 2.76B | |
+9.16% | 45.97B | |
+54.54% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |
- Stock
- Equities
- Stock Evotec SE - Xetra
- Company Evotec SE